Neuromeka Co., Ltd. (KOSDAQ:348340)
16,470
-740 (-4.30%)
Oct 30, 2026, 3:30 PM KST
Neuromeka Revenue
Neuromeka had revenue of 2.82B KRW in the quarter ending June 30, 2026, a decrease of -17.95%. This brings the company's total for the last twelve months to 18.16B, down -13.12% year-over-year. In the year 2025, Neuromeka had annual revenue of 18.95B, down -24.99%. That makes Neuromeka the 35,877th largest company in the world by revenue and 2,297th in South Korea.
Revenue (ttm)
18.16B
Revenue Growth
-13.12%
P/S Ratio
16.89
Revenue / Employee
147.61M
Employees
123
Market Cap
306.57B
Revenue by Geography
- South Korea 17.94B 94.6%
- China 709.19M 3.7%
- USA 239.87M 1.3%
- Other 65.18M 0.3%
Fiscal year ended Dec 31, 2025 See the full Neuromeka breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.95B | -6.32B | -24.99% |
| Dec 31, 2024 | 25.27B | 11.53B | 83.87% |
| Dec 31, 2023 | 13.74B | 3.99B | 40.89% |
| Dec 31, 2022 | 9.75B | 2.40B | 32.69% |
| Dec 31, 2021 | 7.35B | 3.29B | 80.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KHVATEC | 385.82B |
| Worldex Industry & Trading | 295.51B |
| UNISEM | 287.76B |
| Hy-Lok | 224.59B |
| Hantech | 182.21B |
| DAEA TI | 134.04B |
| GemVax&KAEL | 85.10B |
| T-Robotics.Co. | 39.17B |